Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Annals of the New York Academy of Sciences|November 30, 2006
Association of SUMO4, as a candidate gene for IDDM5, with susceptibility to type 1 diabetes in Asian populationsShinsuke Noso, Hiroshi Ikegami, Tomomi Fujisawa, et al.
Hypertension (Dallas, Tex. : 1979)|October 22, 2008
A polymorphism regulates CYP4A11 transcriptional activity and is associated with hypertension in a Japanese populationKen Sugimoto, Hiroshi Akasaka, Tomohiro Katsuya, et al.
Surgery Today|October 24, 2012
Clinicopathological significance of decreased galectin-3 expression and the long-term prognosis in patients with breast cancerSayaka Yamaki, Takaaki Fujii, Reina Yajima, et al.
Diabetes|August 5, 2010
Insulin transactivator MafA regulates intrathymic expression of insulin and affects susceptibility to type 1 diabetesShinsuke Noso, Kohsuke Kataoka, Yumiko Kawabata, et al.
Anticancer Research|January 10, 2014
Early predictive value of non-response to docetaxel in neoadjuvant chemotherapy in breast cancer using 18F-FDG-PETTomoko Hirakata, Yasuhiro Yanagita, Tomomi Fujisawa, et al.
Annals of the New York Academy of Sciences|November 30, 2006
Contribution of class III MHC to susceptibility to type 1 diabetes in the NOD mouseKaori Yamaji, Hiroshi Ikegami, Tomomi Fujisawa, et al.
Autoimmunity|March 23, 2002
Sequence analysis of Tnf as a candidate for Idd16Naru Babaya, Hiroshi Ikegami, Tomomi Fujisawa, et al.
Annals of the New York Academy of Sciences|November 30, 2006
MHC-linked susceptibility to type 1 diabetes in the NOD mouse: further localization of Idd16 by subcongenic analysisTomomi Fujisawa, Hiroshi Ikegami, Shinsuke Noso, et al.
Endocrine Journal|December 18, 2008
A novel mouse model for type 2 diabetes and non-alcoholic fatty liver disease: spontaneous amelioration of diabetes by augmented beta cell massAya Oze-Fukai, Tomomi Fujisawa, Ken Sugimoto, et al.
Surgical Oncology|December 14, 2020
The impact of neoadjuvant systemic therapy on breast conservation rates in patients with HER2-positive breast cancer: Surgical results from a phase II randomized controlled trialTakeshi Yamaguchi, Yasuo Hozumi, Yasuaki Sagara, et al.
Pageof 13